Podcasts

Hosts Jack Arnold, MBBS, PhD, and Rihards Buss, MD, preview the sessions, themes, and abstracts they are most excited about heading into the meeting in London.

Lucy Carter, MBBS, PhD, and our hosts continue their discussion on the journey of B-cell depletion.

Lucy Carter, MBBS, PhD, joins our hosts to discuss how B-cell therapies have evolved for rheumatic disease.

Jack Arnold, MBBS, PhD, and Rihards Buss, MD, discuss early investigations of GLP-1 RAs in rheumatoid arthritis and lupus.

Jack Arnold, MBBS, PhD, and Rihards Buss, MD, discuss the growing use of GLP-1 RAs in the rheumatology field.

Rihards Buss, MD, and Jack Arnolds, MBBS, PhD, discussed the latest data on nipocalimab in lupus and deucravacitinib for PsA.

Joint Ventures is a rheumatology podcast from RheumatologyLive hosted by Jack Arnold, MBBS, PhD, and Rihards Buss, MBBS, exploring the latest news and research in the field.

Discover the latest advancements in diabetes treatment with retatrutide, a promising triple agonist showing significant weight loss and pain relief.

Discover groundbreaking insights on lupus nephritis treatment from the REGENCY trial, highlighting the impact of obintuzumab on patient outcomes.

In this discussion, experts focus on emerging treatment options for gout and share tips for monitoring and managing gout in patients with comorbid conditions.

Expert rheumatologists discuss current treatment options for lupus nephritis and emerging therapies with newer mechanisms of action.

Expert rheumatologists discuss precision medicine in rheumatoid arthritis. In particular, they discuss available data and the value of various tools in guiding treatment selection in routine clinical practice.

In this MEDcast episode, Drs. Soloman, Sharobeem, and Mease discuss newer mechanisms of actions and emerging therapies in rheumatic diseases and tools that are becoming available to rheumatologists to practice precision medicine.

In this MEDcast episode, Drs Soloman, Sharobeem, Boone and Feldman discuss the use of step therapy in rheumatoid arthritis, how step therapy was intended to be used, how it is actually used, and challenges and solutions to its use.

Today's episode of Relatable Rheumatology explores chronic pain in patients with rheumatic disease.

In this episode of Relatable Rheumatology, experts discuss a critically important topic for patients with rheumatoid arthritis: bloodwork and laboratory tests.

In today’s episode, we explore how the lived experience of someone with rheumatoid arthritis can systematically be documented via the use of patient-reported outcome measures.

The podcast will explore the personal experiences of people living with rheumatic diseases and the latest research evidence that informs their diagnosis and treatment.

Dr. John Botson speaks on the new FDA approval of this combination therapy and its strength regarding increased efficacy and safety.

Benjamin Nowell, PhD, and Stuart Silverman, MD, FACP, FACR, discuss the recently published review of current literature regarding cannabis for rheumatic disease pain.

W Benjamin Nowell, PhD, and David Curtis discuss the recent press release announcing updates to the ArthritisPower interface.

In honor of Autoimmune Disease Awareness Month, expert Dr. Joe Ahearn and advocate Michael Linn discuss relapsing polychondritis.

Soumya D. Chakravarty, MD, PhD, discusses the growing body of clinical evidence evaluating joint efficacy, safety, and patient-reported outcomes in patients with psoriatic arthritis receiving guselkumab.

On this month's episode of Overdrive, Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a network meta-analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.

Dr. Curtis speaks to how the new ACR COVID-19 vaccine guidelines further protect patients with rheumatic disease.

Dr. Mease discusses a recent network meta-analyses that included new phase 3 data on guselkumab.

Louis Bessette, MD, MSc, explains the impact of early pain improvement on patient-reported outcomes in patients with psoriatic arthritis.

On this month's episode of Overdrive, Rheumatology Network interviewed Courtney Wells, PhD, MPH, MSW, to discuss the impact of COVID-19 on the quality of life of patients with rheumatic conditions, focusing on perceived risk and decision making.

Soumya Chakravarty, MD, PhD, discusses the unmet patient needs in immune-mediated diseases and Janssen’s role in scientific innovation that allows patients to live their lives unburdened by disease.

On this month's episode of Overdrive, E Michael Lewiecki, MD, discusses recent controversies and trends in osteoporosis management, predictions for 2022, and how COVID-19 impacted the treatment landscape for rheumatologists.